• Loading stock data...
Est. 2004

LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

Friday 05/25/2018
SMALL CAP MARKET NEWS

We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.


LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

  • 12:29 PM

    Video News On PRECISION THERAPEUTICS, INC. – NASDAQ: AIPT   https://youtu.be/G7Vc44qfBMQ     About the STREAMWAY System Skyline’s revolutionary, FDA-cleared STREAMWAY System is the first true direct-to-drain fluid disposal system designed specifically for medical applications, such as radiology, endoscopy, urology and cystoscopy procedures. It connects directly to a facility’s plumbing system to automate the collection, measurement and disposal of waste fluids. The STREAMWAY minimizes human intervention for better safety and improves compliance with Occupational Safety and Health Administration (OSHA) and other regulatory agency

    Read more
  • 10:58 AM

    This will be the first marijuana stock to list on the New York Stock Exchange. Sean Williams (TMFUltraLong) May 21, 2018 at 7:21AM In just over two weeks, the Canadian federal government will be making a game-changing decision for the legal cannabis industry. Its Senate is set to vote on bill C-45, which is more commonly known as the Cannabis Act. Assuming a positive vote, the Cannabis Act, which would legalize recreational marijuana throughout the country, is expected to be quickly moved

    Read more
  • 10:45 AM

    Data Provide Support for PRO 140 as long-acting, HIV-1 maintenance therapy VANCOUVER, Washington, May 24, 2018 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTC.QB:CYDY) announces that results from its CD01 Phase 2b clinical trial and extension study showing the potential of PRO 140, its novel humanized CCR5 monoclonal antibody, as a long-acting, single-agent maintenance therapy for HIV-1 infected patients were published in the peer-reviewed journal HIV Clinical Trials. All HIV-1 infected patients enrolled in the CD01 Phase 2b trial exhibited suppressed viral load

    Read more
  • 1:25 PM

    ATLANTA, GA, , May 24, 2018 (GLOBE NEWSWIRE) — GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, announced today that the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has awarded the Company a Small Business Innovative Research (SBIR) grant in support of its novel Zika vaccine development program. The grant award of $300,000 will fund the second year of a two-year project period with a total budget of $600,000.

    Read more
  • 1:22 PM

    SIMI VALLEY, Calif., May 24, 2018 /PRNewswire/ — Airborne Wireless Network (“Airborne Wireless”) (OTCQB: ABWN) today announced the pricing of an underwritten public offering (“Offering”) of 8,000 units consisting of one share of Series A Convertible Preferred Stock (“Preferred Stock”) and related warrants (“Warrants”) to purchase up to 24,000 shares of Preferred Stock, at a public offering price of $1,000 per unit, for gross proceeds of $8 million, excluding the proceeds, if any, from the exercise of the Warrants. Each share of Preferred Stock is being sold

    Read more
  • 1:16 PM

    BATON ROUGE, LA., May 24, 2018 (GLOBE NEWSWIRE) — Clikia Corp. (OTC PINK: CLKA), provider of ClikiaTV, a streaming (over-the-top, OTT) cable television subscription service, today announced the establishment of its Roku Private Channel, “clikiacorp”, and the completion of the first significant update of its App across the Apple iOS and Google Playstore platforms. This same update for Amazon Fire TV and Apple TV will be completed in June 2018, as will the ClikiaTV Roku Public Channel. “Establishing our ‘clikiacorp’

    Read more
Public Wire Banner